Venglustat

4 trials 1 recruiting Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

2 Sponsors

13 Countries

Phase III

Phase II

Phase III: 3 Phase II: 1

Indications tested

Fabry´s disease 2 Gaucher´s disease type III 1 Gaucher's disease type III 1 Gaucher's disease type I 1

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 3 Genzyme Corp. 1

All trials

4 total

A study to evaluate the effect of venglustat tablets on left ventricular mass index in male and female adult participants with Fabry disease Recruiting

2023-509715-91-00 Phase III 11 countries Sanofi-Aventis Recherche & Developpement
Study to evaluate the efficacy and safety of venglustat in adult and pediatric patients with Gaucher disease Type 3 Ended

2024-514381-39-00 Phase III 3 countries Sanofi-Aventis Recherche & Developpement
A study to evaluate the effect of venglustat tablets on neuropathic and abdominal pain in male and female participants ≥16 years of age with… Ended

2024-511990-31-00 Phase III 10 countries Sanofi-Aventis Recherche & Developpement
Venglustat in Combination with Cerezyme in Adult Patients with Gaucher Disease Type 3 with venglustat monotherapy extension Ended

2023-508646-18-00 Phase II 1 country Genzyme Corp.

Showing 1–4 of 4 trials

← All drugs A–Z